Our Pricing

Wegovy Maintenance Dose: UK Dosing Guide & Bundle Savings

The Wegovy maintenance dose represents the final stage of semaglutide weight loss treatment, where patients continue on 1.7mg or 2.4mg weekly injections to sustain their weight loss results. After completing the initial dose escalation schedule, maintaining consistent treatment at the optimal therapeutic dose is essential for long-term weight management success. At Cured Pharmacy, our UK-registered clinical team provides expert guidance on Wegovy maintenance dosing with transparent pricing from £69.00 per month and bundle options that reduce your cost to £69.00 per pen when purchasing multiple months together.

What Is the Wegovy Maintenance Dose?

The Wegovy maintenance dose is the final therapeutic dose patients reach after completing the gradual dose escalation protocol. In the UK, most patients maintain treatment on either 1.7mg or 2.4mg weekly injections, depending on individual tolerance and clinical response [1]. The maintenance phase begins after approximately 16-20 weeks of gradual dose increases, starting from the initial 0.25mg dose.

Clinical trials demonstrated that the 2.4mg maintenance dose delivered an average weight loss of 14.9% of initial body weight over 68 weeks, compared to 2.4% with placebo [1]. However, our prescribers at Cured Pharmacy recognise that some patients achieve excellent results and tolerate the 1.7mg dose better, making it their optimal maintenance level. The key principle of Wegovy maintenance dosing is consistency—continuing regular weekly injections without interruption to preserve weight loss and metabolic benefits.

Superintendent pharmacist Tarun Kumar (GPhC 2233073) explains that maintenance dosing is not simply about reaching a number on the scale, but establishing a sustainable long-term treatment pattern. Patients on the Wegovy maintenance dose typically continue treatment for 12 months or longer, with regular clinical reviews to assess ongoing suitability and adjust treatment as needed.

Wegovy Maintenance Dose Schedule

The standard Wegovy maintenance dose schedule follows this pattern: Week 1-4 at 0.25mg, Week 5-8 at 0.5mg, Week 9-12 at 1.0mg, Week 13-16 at 1.7mg, and Week 17 onwards at 2.4mg (if tolerated) [2]. This gradual escalation minimises gastrointestinal side effects whilst allowing your body to adjust to increasing semaglutide levels. Once you reach your Wegovy maintenance dose at 1.7mg or 2.4mg, you continue at that same dose weekly for as long as treatment remains clinically appropriate and beneficial.

Wegovy Maintenance Dose Bundle Savings at Cured Pharmacy

Purchasing your Wegovy maintenance dose in multi-month bundles significantly reduces your per-pen cost compared to single-month purchases. At Cured Pharmacy, our bundle pricing structure rewards patients who commit to consistent long-term treatment, which clinical evidence shows is essential for sustained weight loss [3]. When you order a 3-month supply of Wegovy maintenance dose pens, your cost drops to £69.00 per pen, compared to £69.00 for individual monthly orders.

These bundle savings reflect our commitment to making long-term weight management affordable for UK patients. The Wegovy maintenance dose requires ongoing treatment—most patients continue for 12-24 months or longer—so reducing the monthly financial burden improves treatment adherence and outcomes. All bundle orders include free next-day delivery across the UK, 100% discreet packaging, and the same rigorous clinical assessment by our UK-registered prescribers.

New patients can combine bundle pricing with our first-order discount code Weightlossnew for an additional £20 off, making the Wegovy maintenance dose even more accessible. Our transparent pricing model shows all costs upfront before your clinical consultation, with no hidden fees or subscription traps.

Clinical Benefits of Continuing Wegovy Maintenance Dose Treatment

The clinical value of continuing Wegovy maintenance dose treatment extends well beyond the number on the scale. The STEP 4 trial specifically examined what happens when patients stop semaglutide after reaching their maintenance dose: participants who discontinued treatment regained two-thirds of their lost weight within one year, whilst those who continued maintenance dosing sustained their weight loss and even achieved further reductions [3]. This demonstrates that the Wegovy maintenance dose is not a short-term intervention but a long-term management strategy for obesity.

Beyond weight loss, patients maintaining consistent Wegovy maintenance dose treatment experience sustained improvements in cardiovascular risk factors, including blood pressure, lipid profiles, and glycaemic control in those with prediabetes [4]. These metabolic benefits diminish when treatment stops, reinforcing the importance of ongoing maintenance dosing for comprehensive health improvement.

Our clinical team at Cured Pharmacy monitors patients on Wegovy maintenance dose through regular check-ins and clinical reviews. We assess not just weight loss progress but overall tolerability, side effect management, and whether the maintenance dose continues to meet your individual health goals. Some patients may benefit from adjusting their Wegovy maintenance dose between 1.7mg and 2.4mg based on their response and tolerance over time.

Long-Term Weight Maintenance with Wegovy

Long-term data from the STEP trial programme shows that patients who continue their Wegovy maintenance dose for two years or longer maintain clinically significant weight loss, with many achieving additional weight reduction beyond the first year [5]. This contrasts sharply with traditional diet-and-exercise approaches, where most individuals regain lost weight within 12-24 months. The biological mechanisms of semaglutide—reducing appetite, slowing gastric emptying, and modulating reward pathways—remain active only whilst you continue your Wegovy maintenance dose, which explains why ongoing treatment is essential for sustained results.

How to Optimise Your Wegovy Maintenance Dose Results

Achieving optimal results on your Wegovy maintenance dose requires more than simply administering your weekly injection. Clinical trials show that patients who combine semaglutide treatment with structured lifestyle interventions achieve superior outcomes compared to medication alone [1]. At Cured Pharmacy, we recommend patients on the Wegovy maintenance dose adopt a reduced-calorie diet (approximately 500-750 calorie daily deficit) and engage in at least 150 minutes of moderate-intensity physical activity per week.

Timing your Wegovy maintenance dose injection consistently on the same day each week helps maintain stable semaglutide levels and optimises appetite suppression. Many patients find that injecting in the evening reduces the impact of initial nausea, though you can administer your Wegovy maintenance dose at any time of day that suits your routine. Rotating injection sites between your abdomen, thigh, and upper arm prevents lipohypertrophy and ensures consistent absorption.

Managing side effects proactively improves adherence to your Wegovy maintenance dose. Common gastrointestinal effects like nausea, constipation, and bloating typically diminish over time but can be minimised by eating smaller, more frequent meals, staying well-hydrated, and avoiding high-fat foods. If side effects persist or worsen on the 2.4mg Wegovy maintenance dose, our prescribers can assess whether maintaining treatment at 1.7mg provides a better balance of efficacy and tolerability for your individual circumstances.

Wegovy Maintenance Dose vs Other Weight Loss Treatments

When comparing the Wegovy maintenance dose to alternative weight loss medications available in the UK, semaglutide demonstrates superior efficacy in clinical trials. The 2.4mg Wegovy maintenance dose achieved average weight loss of 14.9% compared to 9.5% with tirzepatide 10mg (Mounjaro's mid-range dose) and 6.0% with liraglutide 3mg (Saxenda) over comparable treatment periods [1][6]. However, individual responses vary, and some patients may tolerate or respond better to alternative GLP-1 receptor agonists.

The key advantage of the Wegovy maintenance dose is the once-weekly injection schedule, compared to daily injections required for Saxenda. This convenience factor significantly improves treatment adherence, which directly correlates with weight loss success. Mounjaro (tirzepatide) also offers once-weekly dosing and may produce slightly greater weight loss in some patients, though it works through a dual GIP/GLP-1 mechanism rather than semaglutide's pure GLP-1 action [6].

Cost considerations also influence treatment choice. At Cured Pharmacy, the Wegovy maintenance dose starts from £69.00 monthly (or £69.00 with bundle pricing), making it competitively priced compared to other GLP-1 treatments in the UK market. Our clinical team can discuss whether the Wegovy maintenance dose, Mounjaro, or Saxenda best suits your medical history, weight loss goals, and budget during your free online consultation.

Switching to Wegovy Maintenance Dose from Other Treatments

Patients currently using Saxenda or other weight loss medications can transition to the Wegovy maintenance dose under prescriber guidance. The switch typically involves starting Wegovy at the initial 0.25mg dose and following the standard escalation schedule, even if you've previously used other GLP-1 treatments. This gradual approach minimises side effects and allows your body to adjust to semaglutide's specific pharmacological profile. Our UK-registered prescribers at Cured Pharmacy assess your previous treatment response and medical history to determine the most appropriate transition protocol for your individual circumstances.

Ordering Your Wegovy Maintenance Dose from Cured Pharmacy

Ordering your Wegovy maintenance dose from Cured Pharmacy is straightforward and fully compliant with UK pharmacy regulations. All patients complete a free online clinical assessment that takes under 3 minutes, reviewed by our UK-registered prescribers who determine whether Wegovy is clinically appropriate for your circumstances. This assessment covers your medical history, current medications, weight loss goals, and any contraindications to semaglutide treatment.

Once approved, your Wegovy maintenance dose prescription is dispensed from our GPhC-registered pharmacy (registration number 9012511) and dispatched via next-day delivery in 100% discreet packaging. We supply only genuine UK-licensed Wegovy pens manufactured by Novo Nordisk, never grey-market or unlicensed alternatives. Your medication arrives with full patient information leaflets and injection instructions, plus access to our pharmacist support team for any questions about your Wegovy maintenance dose.

Ongoing prescriptions for your Wegovy maintenance dose require periodic clinical reviews to ensure treatment remains safe and effective. Our system prompts you to complete follow-up assessments at appropriate intervals, allowing our prescribers to monitor your progress, adjust dosing if needed, and address any concerns. This clinical oversight ensures your Wegovy maintenance dose treatment meets the highest standards of pharmaceutical care whilst remaining convenient and accessible from the comfort of your home.

Wegovy Maintenance Dose Delivery and Support

Every Wegovy maintenance dose order includes free next-day delivery across the UK, with temperature-controlled packaging to maintain medication integrity during transit. We dispatch Monday through Friday, with orders placed before 3pm typically arriving the following business day. Our customer care team is available on (+44) 116 4646009 for delivery tracking, clinical questions, or prescription queries. Superintendent pharmacist Tarun Kumar oversees all clinical aspects of your Wegovy maintenance dose treatment, ensuring you receive expert pharmaceutical care throughout your weight loss journey.

Scientific References

1. Wilding, J. P. H., Batterham, R. L., Calanna, S., Davies, M., Van Gaal, L. F., Lingvay, I., ... & Kushner, R. F. (2021). Once-weekly semaglutide in adults with overweight or obesity. New England Journal of Medicine, 384(11), 989-1002. [accessed 15 August 2026]
2. Novo Nordisk. (2023). Wegovy 2.4 mg solution for injection in pre-filled pen: Summary of Product Characteristics. Electronic Medicines Compendium. [accessed 15 August 2026]
3. Rubino, D., Abrahamsson, N., Davies, M., Hesse, D., Greenway, F. L., Jensen, C., ... & Wadden, T. A. (2021). Effect of continued weekly subcutaneous semaglutide vs placebo on weight loss maintenance in adults with overweight or obesity: the STEP 4 randomized clinical trial. JAMA, 325(14), 1414-1425. [accessed 15 August 2026]
4. Davies, M., Færch, L., Jeppesen, O. K., Pakseresht, A., Pedersen, S. D., Perreault, L., ... & Lingvay, I. (2021). Semaglutide 2.4 mg once a week in adults with overweight or obesity, and type 2 diabetes (STEP 2): a randomised, double-blind, double-dummy, placebo-controlled, phase 3 trial. The Lancet, 397(10278), 971-984. [accessed 15 August 2026]
5. Garvey, W. T., Batterham, R. L., Bhatta, M., Buscemi, S., Christensen, L. N., Frias, J. P., ... & Wharton, S. (2022). Two-year effects of semaglutide in adults with overweight or obesity: the STEP 5 trial. Nature Medicine, 28(10), 2083-2091. [accessed 15 August 2026]
6. Jastreboff, A. M., Aronne, L. J., Ahmad, N. N., Wharton, S., Connery, L., Alves, B., ... & Bunck, M. C. (2022). Tirzepatide once weekly for the treatment of obesity. New England Journal of Medicine, 387(3), 205-216. [accessed 15 August 2026]
7. NHS. (2026). Tirzepatide: a medicine to manage type 2 diabetes and treat obesity. https://www.nhs.uk/medicines/tirzepatide/ Accessed 15 August 2026.
8. NHS. (2026). Overweight and obesity in adults. https://www.nhs.uk/conditions/overweight-and-obesity/ Accessed 15 August 2026.
9. NHS England. (2026). Weight management injections. https://www.england.nhs.uk/ourwork/prevention/obesity/medicines-for-obesity/weight-management-injections/ Accessed 15 August 2026.

Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Always consult a qualified healthcare professional before starting any new medication.